Key genetic variants, such as those located in the PNPLA3, TM6SF2, and MBOAT7 genes, often interact to exacerbate MASLD severity and play key roles in lipid metabolism and liver inflammation. This evidence concerns the gene PNPLA3 and metabolic dysfunction-associated steatotic liver disease.